Guillaume Dorval is an Assistant Professor of Genetics at Université Paris-Cité and a clinician at Hôpital Necker-Enfants Malades, where he integrates clinical nephrology with molecular genetics. Following his clinical fellowships in both specialties, and a genetic research fellowship at Harvard University, his work now focuses on advancing precision medicine for rare inherited kidney diseases.

His research and clinical practice are dedicated to the journey from molecular diagnosis to innovative therapeutics. Dr. Dorval is particularly involved in exploring DNA and RNA-based targeted strategies, such as gene therapy and antisense oligonucleotides (ASOs), for monogenic renal disorders.
As a committed member of the international renal community, he serves as Chair of the Hereditary Glomerulopathies Group within the European Rare Kidney Disease Reference Network (ERKNet). His goal is to foster a deeper synergy between genomic discovery and the development of life-changing treatments for patients.